- Healthcare Professionals
- Research
- Clinical trials
- Elevate study
Elevate Study
A Multicentre, Open-label, Randomised, Phase IV Study to Investigate Acalabrutinib Monotherapy Compared to Investigator’s Choice of Treatment in Adults (> 18 Years) With Chronic Lymphocytic Leukaemia and Moderate to Severe Cardiac Impairment
Trial overview
Disease
Haematology
Topic
Diagnostics
Sponsor
Astra Zeneca
Description
A Multicentre, Open-label, Randomised, Phase IV Study to Investigate Acalabrutinib Monotherapy Compared to Investigator’s Choice of Treatment in Adults (> 18 Years) With Chronic Lymphocytic Leukaemia and Moderate to Severe Cardiac Impairment
Study details
To follow
Trial status
Opening August 2024
Location
Priniciple Investigator
Dr Toby Eyre
MBChB (Hons), DipMedEd, MRCP (UK), FRCPath (UK), MD (University of Newcastle)
Consultant Haematologist
Oxford
